Approvals & regulatory · first seen 19h ago, updated 19h ago
EC approves first triple-combination therapy for asthma maintenance
AstraZeneca’s fixed-dose triple-combination Trixeo Aerosphere (budesonide/glycopyrronium/formoterol fumarate dihydrate or BGF) has been approved in the European Union (EU) as a maintenance treatment for asthma. It is approved in patients 12…
Summary from DDW Drug Discovery World.
Coverage 1 article · 1 outlet
-
DDW Drug Discovery WorldEC approves first triple-combination therapy for asthma maintenance